|
VPS26A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14290000019501E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.1363999996572E-07 |
| Normal-vs-Stage2 |
1.658630E-03 |
| Normal-vs-Stage3 |
4.123800E-03 |
| Normal-vs-Stage4 |
1.141580E-01 |
| Stage1-vs-Stage2 |
5.149200E-01 |
| Stage1-vs-Stage3 |
5.730600E-01 |
| Stage1-vs-Stage4 |
4.872000E-01 |
| Stage2-vs-Stage3 |
8.899400E-01 |
| Stage2-vs-Stage4 |
8.131600E-01 |
| Stage3-vs-Stage4 |
7.567600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.19369999837826E-08 |
| Normal-vs-AfricanAmerican |
4.784700E-04 |
| Normal-vs-Asian |
4.687600E-01 |
| Caucasian-vs-AfricanAmerican |
3.200200E-01 |
| Caucasian-vs-Asian |
4.290600E-01 |
| AfricanAmerican-vs-Asian |
6.698800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.07429995191922E-10 |
| Normal-vs-Female |
1.889250E-01 |
| Male-vs-Female |
3.65940000000009E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.61399999999823E-05 |
| Normal-vs-Extreme_Weight |
2.72199995876576E-09 |
| Normal-vs-Obese |
2.760500E-04 |
| Normal-vs-Extreme_Obese |
1.174480E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.062800E-01 |
| Normal_Weight-vs-Obese |
2.181400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.584600E-01 |
| Extreme_Weight-vs-Obese |
3.020500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.229600E-01 |
| Obese-vs-Extreme_Obese |
3.208400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.136400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.25200000000459E-05 |
| Normal-vs-Age(61-80Yrs) |
7.22689996734971E-09 |
| Normal-vs-Age(81-100Yrs) |
1.82880999999302E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.438450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.709870E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.465600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.331900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.098620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.353000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.11860000046238E-08 |
| Normal-VS-Type2 PRCC |
6.62100000048405E-07 |
| Normal-VS-KIRP CIMP |
3.891200E-01 |
| Normal-VS-Unclassified PRCC |
6.000500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.231800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.763600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.440800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.283160E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.238000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.161600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.41339997670332E-09 |
| Normal-vs-N1 |
1.428400E-01 |
| Normal-vs-N2 |
2.401600E-01 |
| N0-vs-N1 |
6.020500E-03 |
| N0-vs-N2 |
7.126200E-01 |
| N1-vs-N2 |
4.014400E-01 |
|
|
